| Tocilizumab | Influence on protein activity in tumor tissue | Western Blot | 5.00 mg/kg | UM-HMC-3B (xenograft) | Mus musculus | C.B-17 scid |  |  | 
                
                    
                        | Tocilizumab | Influence on protein activity in tumor tissue | Western Blot | 5.00 mg/kg | UM-HMC-3B (xenograft) | Mus musculus | C.B-17 scid |  |  | 
                
                    
                        | Tocilizumab | Influence on protein activity in tumor tissue | Western Blot | 5.00 mg/kg | UM-HMC-3B (xenograft) | Mus musculus | C.B-17 scid |  |  | 
                
                    
                        | Tocilizumab | Influence on protein activity in tumor tissue | Western Blot | 5.00 mg/kg | UM-HMC-3B (xenograft) | Mus musculus | C.B-17 scid |  |  | 
                
                    
                        | Tocilizumab | Influence on protein activity in tumor tissue | Western Blot | 5.00 mg/kg | UM-HMC-3B (xenograft) | Mus musculus | C.B-17 scid |  |  | 
                
                    
                        | Tocilizumab | Influence on protein activity | Western Blot | 0.00 µM | UM-HMC-1 | Homo sapiens |  | p-STAT3 |  | 
                
                    
                        | Tocilizumab | Influence on protein activity | Western Blot | 0.01 µM | UM-HMC-1 | Homo sapiens |  | p-STAT3 |  | 
                
                    
                        | Tocilizumab | Influence on protein activity | Western Blot | 0.10 µM | UM-HMC-1 | Homo sapiens |  | p-STAT3 |  | 
                
                    
                        | Tocilizumab | Influence on protein activity | Western Blot | 0.00 µM | UM-HMC-1 | Homo sapiens |  | STAT3 |  | 
                
                    
                        | Tocilizumab | Influence on protein activity | Western Blot | 0.01 µM | UM-HMC-1 | Homo sapiens |  | STAT3 |  | 
                
                    
                        | Tocilizumab | Influence on protein activity | Western Blot | 0.10 µM | UM-HMC-1 | Homo sapiens |  | STAT3 |  | 
                
                    
                        | Tocilizumab | Influence on protein activity | Western Blot | 0.00 µM | UM-HMC-1 | Homo sapiens |  |  |  | 
                
                    
                        | Tocilizumab | Influence on protein activity | Western Blot | 0.01 µM | UM-HMC-1 | Homo sapiens |  |  |  | 
                
                    
                        | Tocilizumab | Influence on protein activity | Western Blot | 0.10 µM | UM-HMC-1 | Homo sapiens |  |  |  | 
                
                    
                        | Tocilizumab | Influence on protein activity | Western Blot | 0.00 µM | UM-HMC-1 | Homo sapiens |  |  |  | 
                
                    
                        | Tocilizumab | Influence on protein activity | Western Blot | 0.01 µM | UM-HMC-1 | Homo sapiens |  |  |  | 
                
                    
                        | Tocilizumab | Influence on protein activity | Western Blot | 0.10 µM | UM-HMC-1 | Homo sapiens |  |  |  | 
                
                    
                        | Tocilizumab | Influence on protein activity | Western Blot | 0.00 µM | UM-HMC-1 | Homo sapiens |  |  |  | 
                
                    
                        | Tocilizumab | Influence on protein activity | Western Blot | 0.01 µM | UM-HMC-1 | Homo sapiens |  |  |  | 
                
                    
                        | Tocilizumab | Influence on protein activity | Western Blot | 0.10 µM | UM-HMC-1 | Homo sapiens |  |  |  | 
                
                    
                        | Tocilizumab | Influence on protein activity | Western Blot | 0.00 µM | UM-HMC-1 | Homo sapiens |  |  |  | 
                
                    
                        | Tocilizumab | Influence on protein activity | Western Blot | 0.01 µM | UM-HMC-1 | Homo sapiens |  |  |  | 
                
                    
                        | Tocilizumab | Influence on protein activity | Western Blot | 0.10 µM | UM-HMC-1 | Homo sapiens |  |  |  | 
                
                    
                        | Tocilizumab | Influence on protein activity | Western Blot | 0.00 µM | UM-HMC-1 | Homo sapiens |  |  |  | 
                
                    
                        | Tocilizumab | Influence on protein activity | Western Blot | 0.01 µM | UM-HMC-1 | Homo sapiens |  |  |  | 
                
                    
                        | Tocilizumab | Influence on protein activity | Western Blot | 0.10 µM | UM-HMC-1 | Homo sapiens |  |  |  | 
                
                    
                        | Tocilizumab | Influence on protein activity in presence of rhIL-6 | Western Blot | 0.00 µM | UM-HMC-3B | Homo sapiens |  | p-STAT3 |  | 
                
                    
                        | Tocilizumab | Influence on protein activity in presence of rhIL-6 | Western Blot | 0.01 µM | UM-HMC-3B | Homo sapiens |  | p-STAT3 |  | 
                
                    
                        | Tocilizumab | Influence on protein activity in presence of rhIL-6 | Western Blot | 0.10 µM | UM-HMC-3B | Homo sapiens |  | p-STAT3 |  | 
                
                    
                        | Tocilizumab | Influence on protein activity in presence of rhIL-6 | Western Blot | 0.00 µM | UM-HMC-3B | Homo sapiens |  | STAT3 |  | 
                
                    
                        | Tocilizumab | Influence on protein activity in presence of rhIL-6 | Western Blot | 0.01 µM | UM-HMC-3B | Homo sapiens |  | STAT3 |  | 
                
                    
                        | Tocilizumab | Influence on protein activity in presence of rhIL-6 | Western Blot | 0.10 µM | UM-HMC-3B | Homo sapiens |  | STAT3 |  | 
                
                    
                        | Tocilizumab | Influence on protein activity in presence of rhIL-6 | Western Blot | 0.00 µM | UM-HMC-3B | Homo sapiens |  |  |  | 
                
                    
                        | Tocilizumab | Influence on protein activity in presence of rhIL-6 | Western Blot | 0.01 µM | UM-HMC-3B | Homo sapiens |  |  |  | 
                
                    
                        | Tocilizumab | Influence on protein activity in presence of rhIL-6 | Western Blot | 0.10 µM | UM-HMC-3B | Homo sapiens |  |  |  | 
                
                    
                        | Tocilizumab | Influence on protein activity in presence of rhIL-6 | Western Blot | 0.00 µM | UM-HMC-3B | Homo sapiens |  |  |  | 
                
                    
                        | Tocilizumab | Influence on protein activity in presence of rhIL-6 | Western Blot | 0.01 µM | UM-HMC-3B | Homo sapiens |  |  |  | 
                
                    
                        | Tocilizumab | Influence on protein activity in presence of rhIL-6 | Western Blot | 0.10 µM | UM-HMC-3B | Homo sapiens |  |  |  | 
                
                    
                        | Tocilizumab | Influence on protein activity in presence of rhIL-6 | Western Blot | 0.00 µM | UM-HMC-3B | Homo sapiens |  |  |  | 
                
                    
                        | Tocilizumab | Influence on protein activity in presence of rhIL-6 | Western Blot | 0.01 µM | UM-HMC-3B | Homo sapiens |  |  |  | 
                
                    
                        | Tocilizumab | Influence on protein activity in presence of rhIL-6 | Western Blot | 0.10 µM | UM-HMC-3B | Homo sapiens |  |  |  | 
                
                    
                        | Tocilizumab | Influence on protein activity in presence of rhIL-6 | Western Blot | 0.00 µM | UM-HMC-3B | Homo sapiens |  |  |  | 
                
                    
                        | Tocilizumab | Influence on protein activity in presence of rhIL-6 | Western Blot | 0.01 µM | UM-HMC-3B | Homo sapiens |  |  |  | 
                
                    
                        | Tocilizumab | Influence on protein activity in presence of rhIL-6 | Western Blot | 0.10 µM | UM-HMC-3B | Homo sapiens |  |  |  | 
                
                    
                        | Tocilizumab | Influence on protein activity in presence of rhIL-6 | Western Blot | 0.00 µM | UM-HMC-3B | Homo sapiens |  |  |  | 
                
                    
                        | Tocilizumab | Influence on protein activity in presence of rhIL-6 | Western Blot | 0.01 µM | UM-HMC-3B | Homo sapiens |  |  |  | 
                
                    
                        | Tocilizumab | Influence on protein activity in presence of rhIL-6 | Western Blot | 0.10 µM | UM-HMC-3B | Homo sapiens |  |  |  | 
                
                    
                        | Tocilizumab | Influence on protein activity in presence of conditionend medium | Western Blot | 0.00 µM | UM-HMC-3B | Homo sapiens |  | p-STAT3 |  | 
                
                    
                        | Tocilizumab | Influence on protein activity in presence of conditionend medium | Western Blot | 0.01 µM | UM-HMC-3B | Homo sapiens |  | p-STAT3 |  | 
                
                    
                        | Tocilizumab | Influence on protein activity in presence of conditionend medium | Western Blot | 0.10 µM | UM-HMC-3B | Homo sapiens |  | p-STAT3 |  |